Autor: "August, Keith J" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Tisagenlecleucel Model-Based Cellular Kinetic Analysis of Chimeric Antigen Receptor-T Cells.
Autorzy:: Stein AM; Novartis Institutes for BioMedical Research, Cambridge, Massachusetts, USA.
Grupp SA; Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Division of Oncology, Center for Childhood Cancer Research and Cancer Immunotherapy Program, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Levine JE; University of Michigan, Ann Arbor, Michigan, USA.; Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Laetsch TW; Department of Pediatrics, The University of Texas Southwestern Medical Center, Dallas, Texas, USA.; Pauline Allen Gill Center for Cancer and Blood Disorders, Children's Health, Dallas, Texas, USA.
Pulsipher MA; Division of Hematology, Oncology, and Blood and Marrow Transplantation, Children's Hospital Los Angeles, Keck School of Medicine of University of Southern California, Los Angeles, California, USA.
Boyer MW; Department of Pediatrics and Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
August KJ; Children's Mercy Hospital Kansas City, Kansas City, Missouri, USA.
Levine BL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Tomassian L; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Shah S; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Leung M; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Huang PH; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
Awasthi R; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA.
Mueller KT; Novartis Institutes for BioMedical Research, East Hanover, New Jersey, USA.
Wood PA; Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA.
June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Pokaż więcej
Źródło:: CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2019 May; Vol. 8 (5), pp. 285-295. Date of Electronic Publication: 2019 Mar 07.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:: Antibodies, Monoclonal, Humanized/*therapeutic use
Lymphoma, Large B-Cell, Diffuse/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Receptors, Antigen, T-Cell/*administration & dosage
Adolescent ; Adult ; Child ; Child, Preschool ; Clinical Trials, Phase II as Topic ; Female ; Half-Life ; Humans ; Immunotherapy, Adoptive ; Male ; Models, Theoretical ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology ; Young Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""August, Keith J"" wg kryterium: Autor

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Język